Guía de Práctica Clínica sobre Cuidados Paliativos - Cedepap TV

87. Breitbart W, Payne D, Passik SD. Psychological and psychiatric interventions in pain control.In: Doyle D, Hanks G, Chreney N, Calman K, editors. Oxford Textbook of Palliative Medicine.Third ed. Oxford: Oxford University Press; 2004.88. Control of pain in patients with cancer. Draft Guideline. Edinburgh: Scottish IntercollegiateGuidelines Network (SIGN); 2007.89. Carr DB, Goudas LC, Balk EM, Bloch R, Ioannidis JP, Lau J. Evidence report on the treatmentof pain in cancer patients. J Natl Cancer Inst Monogr. 2004;(32):23-31.90. Caraceni A, Cherny N, Fainsinger R, Kaasa S, Poulain P, Radbruch L, et al. Pain measurementtools and methods in clinical research in palliative care: recommendations of an Expert WorkingGroup of the European Association of Palliative Care. J Pain Symptom Manage.2002;23(3):239-55.91. Zwakhalen SM, Hamers JP, bu-Saad HH, Berger MP. Pain in elderly people with severedementia: a systematic review of behavioural pain assessment tools. BMC Geriatr. 2006;6:3.92. McNicol E, Strassels SA, Goudas L, Lau J, Carr DB. NSAIDS or paracetamol, alone or combinedwith opioids, for cancer pain. Cochrane Database Syst Rev. 2005;(1):CD005180.93. Nicholson AB. Methadone for cancer pain. Cochrane Database Syst Rev. 2004;(2):CD003971.94. Wiffen PJ, Edwards JE, Barden J, McQuay HJ. Oral morphine for cancer pain. CochraneDatabase Syst Rev. 2003;(4):CD003868.95. Jadad AR, Browman GP. The WHO analgesic ladder for cancer pain management. Steppingup the quality of its evaluation. JAMA. 1995;274(23):1870-3.96. Azevedo Sao Leao FK, Kimura M, Jacobsen TM. The WHO analgesic ladder for cancer paincontrol, twenty years of use. How much pain relief does one get from using it? Support CareCancer. 2006;14(11):1086-93.97. Miguel R. Interventional treatmente of cancer Pain:The Fourth Step in the World HealthOrganization Analgesic Ladder? Cancer Control. 2000;7(2):149-56.98. Williams JE, Louw G, Towlerton G. Intrathecal pumps for giving opioids in chronic pain: asystematic review. Health Technol Assess. 2000;4(32):iii-65.99. Smith TJ, Staats PS, Deer T, Stearns LJ, Rauck RL, Boortz-Marx RL, et al. Randomizedclinical trial of an implantable drug delivery system compared with comprehensive medicalmanagement for refractory cancer pain: impact on pain, drug-related toxicity, and survival. JClin Oncol. 2002;20(19):4040-9.100. Stearns L, Boortz-Marx R, Du PS, Friehs G, Gordon M, Halyard M, et al. Intrathecal drugdelivery for the management of cancer pain: a multidisciplinary consensus of best clinicalpractices. J Support Oncol. 2005;3(6):399-408.101. Leppert W, Luczak J. The role of tramadol in cancer pain treatment--a review. Support CareCancer. 2005;13(1):5-17.102. Reid CM, Martin RM, Sterne JAC, Davies AN, Hanks GW. Oxycodone for cancer-relatedpain: Meta-analysis of randomized controlled trials. Archives of Internal Medicine.2006;166(8):837-43.103. Moore RA, McQuay HJ. Prevalence of opioid adverse events in chronic non-malignant pain:systematic review of randomised trials of oral opioids. Arthritis Res Ther. 2005;7(5):R1046-R1051.292 GUÍAS DE PRÁCTICA CLÍNICA EN EL SNS